NSD2 and lung cancer: Additionally, lung cancer demonstrated upregulation of 10 more methyltransferases, namely DNMT3B, SMYD5, EHMT2, SUV39H2, WHSC1, PRDM15, and PRMTs 1, 3, 4, and 6.